Loading...
Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) – a feasibility study.
Haslett, Kate Ashcroft, Linda Franks, K Groom, N Hannah, G Harden, S Harris, C Harrow, S Hatton, M
Haslett, Kate
Ashcroft, Linda
Franks, K
Groom, N
Hannah, G
Harden, S
Harris, C
Harrow, S
Hatton, M
Citations
Altmetric:
Abstract
Description
Date
2018-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) – a feasibility study. 2018, 115(Suppl_1): S62 Lung Cancer